Ignite Creation Date:
2025-12-24 @ 10:54 PM
Ignite Modification Date:
2026-01-02 @ 3:52 AM
Study NCT ID:
NCT02228369
Status:
COMPLETED
Last Update Posted:
2021-01-05
First Post:
2014-08-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung Cancer
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11-05
Start Date Type:
ACTUAL
Primary Completion Date:
2017-08-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-28
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-20
First Submit QC Date:
None
Study First Post Date:
2014-08-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-04
Last Update Post Date:
2021-01-05
Last Update Post Date Type:
ACTUAL